An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
TianMei Si,1 QingRong Tan,2 KeRang Zhang,3 Yang Wang,4 Qing Rui4 1Peking University Institute of Mental health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, 2Fourth Military Medical University, First Hospital, Xi’an, 3Shanxi Medical University, First Ho...
Main Authors: | Si TM, Tan QR, Zhang KR, Wang Y, Rui Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/an-open-label-flexible-dose-study-of-paliperidone-extended-release-in--peer-reviewed-article-NDT |
Similar Items
-
Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study
by: Si TM, et al.
Published: (2015-06-01) -
Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients
by: Gang Wang, et al.
Published: (2020-04-01) -
Treatment of bipolar mania with paliperidone extended-release
by: Paterakis Periklis, et al.
Published: (2010-04-01) -
Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
by: Yang FD, et al.
Published: (2017-04-01) -
Evaluation of sleep profile in schizophrenia patients treated with extended-release paliperidone: an open-label prospective study in Southeast Asia
by: Kongsakon R, et al.
Published: (2017-10-01)